Form 4 for GLSI Greenwich LifeSciences, Inc.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001493152-24-007077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | 2024-02-15 | GLSI | Patel Snehal | CEO, CFO, Dir, 10% | P - Purchase | $11.07 | +12.7K | 5.33M | +0.2% | +$140.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | P | A | 12,700 | $11.07 | 5,325,377 | D | — | — |